Literature DB >> 11939977

Psychiatric symptoms in neurologically asymptomatic Huntington's disease gene carriers: a comparison with gene negative at risk subjects.

G E Berrios1, A C Wagle, I S Marková, S A Wagle, A Rosser, J R Hodges.   

Abstract

OBJECTIVE: Psychiatric profiles of two at-risk groups [Huntington's disease (HD) gene carriers and non-carriers] were compared by means of a computerized battery and a structured interview.
METHOD: To avoid confounding, only subjects who were free from neurological and cognitive deficits (neurologically asymptomatic) were included in the study. To avoid evaluation biases, all subjects were seen before the genetic testing was undertaken.
RESULTS: Gene carriers had significantly worse recognition memory and scored higher in measures of irritability than controls. The groups also differed in terms of the factor structure of their psychiatric symptoms. None of the subjects qualified for a psychiatric diagnosis at the time of assessment.
CONCLUSION: The groups differed with respect to their profile of psychiatric symptoms. It is hypothesized that these differences are the expression of different mechanisms, i.e. that cognitive deficits relate more to genetic factors and neurotic complaints more to being brought up in a disturbed family background. Issues concerning instrument sensitivity, selection bias and the advantage of seriatim assessments are discussed.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11939977     DOI: 10.1034/j.1600-0447.2002.0o456.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  25 in total

1.  Increased irritability, anxiety, and immune reactivity in transgenic Huntington's disease monkeys.

Authors:  Jessica Raper; Steven Bosinger; Zachary Johnson; Gregory Tharp; Sean P Moran; Anthony W S Chan
Journal:  Brain Behav Immun       Date:  2016-07-07       Impact factor: 7.217

2.  Depression and suicidal ideation after predictive testing for Huntington's disease: a two-year follow-up study.

Authors:  Maria U Larsson; Mary A Luszcz; The-Hung Bui; Tarja-Brita Robins Wahlin
Journal:  J Genet Couns       Date:  2006-10       Impact factor: 2.537

Review 3.  "Pre-symptomatic" Huntington's disease.

Authors:  Kevin Duff; Leigh J Beglinger; Jane S Paulsen
Journal:  Handb Clin Neurol       Date:  2008

4.  Early Detection of Huntington Disease.

Authors:  Jane S Paulsen
Journal:  Future Neurol       Date:  2010-01

5.  Validation of Neuro-QoL and PROMIS Mental Health Patient Reported Outcome Measures in Persons with Huntington Disease.

Authors:  Noelle E Carlozzi; Siera Goodnight; Anna L Kratz; Julie C Stout; Michael K McCormack; Jane S Paulsen; Nicholas R Boileau; David Cella; Rebecca E Ready
Journal:  J Huntingtons Dis       Date:  2019

6.  Neurotrophin receptor p75(NTR) mediates Huntington's disease-associated synaptic and memory dysfunction.

Authors:  Verónica Brito; Albert Giralt; Lilian Enriquez-Barreto; Mar Puigdellívol; Nuria Suelves; Alfonsa Zamora-Moratalla; Jesús J Ballesteros; Eduardo D Martín; Nuria Dominguez-Iturza; Miguel Morales; Jordi Alberch; Sílvia Ginés
Journal:  J Clin Invest       Date:  2014-09-02       Impact factor: 14.808

7.  Prevalence of incompletely penetrant Huntington's disease alleles among individuals with major depressive disorder.

Authors:  Roy H Perlis; Jordan W Smoller; Jayalakshmi Mysore; Mei Sun; Tammy Gillis; Shaun Purcell; Marcella Rietschel; Markus M Nöthen; Stephanie Witt; Wolfgang Maier; Dan V Iosifescu; Patrick Sullivan; A John Rush; Maurizio Fava; Hans Breiter; Marcy Macdonald; James Gusella
Journal:  Am J Psychiatry       Date:  2010-04-01       Impact factor: 18.112

8.  Psychiatric disorders in preclinical Huntington's disease.

Authors:  Camille L Julien; Jennifer C Thompson; Sue Wild; Pamela Yardumian; Julie S Snowden; Gwen Turner; David Craufurd
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-12-18       Impact factor: 10.154

9.  Clinical impairment in premanifest and early Huntington's disease is associated with regionally specific atrophy.

Authors:  Rachael I Scahill; Nicola Z Hobbs; Miranda J Say; Natalie Bechtel; Susie M D Henley; Harpreet Hyare; Douglas R Langbehn; Rebecca Jones; Blair R Leavitt; Raymund A C Roos; Alexandra Durr; Hans Johnson; Stéphane Lehéricy; David Craufurd; Christopher Kennard; Stephen L Hicks; Julie C Stout; Ralf Reilmann; Sarah J Tabrizi
Journal:  Hum Brain Mapp       Date:  2011-11-18       Impact factor: 5.038

10.  Alterations in cortical excitation and inhibition in genetic mouse models of Huntington's disease.

Authors:  Damian M Cummings; Véronique M André; Besim O Uzgil; Steven M Gee; Yvette E Fisher; Carlos Cepeda; Michael S Levine
Journal:  J Neurosci       Date:  2009-08-19       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.